Results 121 to 130 of about 244,568 (170)
Some of the next articles are maybe not open access.

Use of Norethindrone Acetate Alone for Postoperative Suppression of Endometriosis Symptoms

Journal of Pediatric and Adolescent Gynecology, 2012
To evaluate the efficacy and tolerability of norethindrone acetate (NA) as single-agent hormonal therapy for suppression of endometriosis symptoms in adolescents and young adults.Retrospective study.Two academic medical centers.A keyword search using the query 'NA' was applied to the electronic medical records of all women treated by one gynecologist ...
Stacey Missmer   +2 more
exaly   +3 more sources

Bioavailability of norethindrone in women and rabbits after administration of norethindrone acetate through the subcutaneous route

Experientia, 1982
The levels of available norethindrone were found to be similar in women and rabbits after s.c. administration of crystalline and amorphous, norethindrone acetate respectively, and this study indicates that the rabbit may be used as an animal model for further investigation with this contraceptive steroid.
K R Laumas, V Hingorani, N N Sarkar
exaly   +2 more sources

Norethindrone acetate inhibition of triglyceride synthesis and release by rat hepatocytes

Atherosclerosis, 1983
The progestin, norethindrone acetate has been widely administered to patients in the form of oral contraceptives; however, its hypolipemic action has received little study. This report describes the effects of conventional doses of norethindrone acetate (100 micrograms/day.kg body weight 0.75) on rat plasma lipid levels in vivo as well as the mechanism
B M Wolfe
exaly   +3 more sources

Absorption of Chlormadinone Acetate and Norethindrone from In Situ Rat Gut

Journal of Pharmaceutical Sciences, 1973
The GI absorption of chlormadinone acetate and norethindrone was studied in a rat in situ preparation. The data evaluated with respect to the absorption half-life in the ligated stomach and intestine suggest that chlormadinone acetate is absorbed slightly more rapidly than norethindrone and that both steroids are absorbed to a greater extent in the ...
exaly   +3 more sources

Pharmacokinetics of norethindrone acetate in women

American Journal of Obstetrics and Gynecology, 1979
The plasma half-life, MCR and plasma metabolite levels at various time intervals have been studied in six women after an intravenous injection of 3H-norethindrone acetate. The disappearance curve due to norethindrone acetate showed an initial rapid disappearance of 3H with an average half-life of 7.5 minutes and a subsequent slow disapperance with a ...
H, Singh   +6 more
openaire   +2 more sources

Jaundice Associated with Norethindrone Acetate Therapy

New England Journal of Medicine, 1962
METHYLTESTOSTERONE has been known to be associated with jaundice and tissue evidence of biliary cholestasis, as mentioned by Werner in 19501 and by subsequent authors.2 Certain modifications of the...
R A, PEREZ-MERA, C E, SHIELDS
openaire   +2 more sources

Pharmacokinetics of norethindrone acetate in women after the insertion of a single subdermal implant releasing norethindrone acetate

Acta Endocrinologica, 1982
Abstract. The metabolic clearance rate (MCR) of norethindrone acetate1 (NETA) and norethindrone (NET) levels in plasma were studied after an iv injection of [3H]NETA in three women before and at 1 week, 1, 2 and 6 months following the insertion of a single silastic subdermal implant releasing microquantities of NETA. No significant change in the MCR of
H, Singh   +6 more
openaire   +2 more sources

Norethindrone in Serum After use of an oral Contraceptive Containing Norethindrone Acetate

Acta Obstetricia et Gynecologica Scandinavica, 1983
Abstract. The availability of norethindrone (NET) in serum was studied in 8 women after daily administration of a combination oral contraceptive pill (MinovlarR) containing 1 mg norethindrone acetate (NETA) and 50 μg ethinyl estradiol (EE2) from day 5 to day 25 of the menstrual cycle. The pill was taken daily at 9.30 a.m.
N N, Sarkar   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy